Bladder Cancer
1,100
189
270
478
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
165 trials with published results (15%)
Research Maturity
478 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.5%
104 terminated out of 1100 trials
82.1%
-4.4% vs benchmark
10%
108 trials in Phase 3/4
35%
165 of 478 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 478 completed trials
Clinical Trials (1100)
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
AI-Guided TURBT for Bladder Cancer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
A Randomised Trial Investigating the Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
IDOV-Immune for Advanced Solid Tumors
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
DESTINY-PANTUMOUR04